A 4-year-old child is diagnosed with pulmonary tuberculosis and started on standard 4-drug ATT (HRZE). After 2 weeks of treatment, the child develops sudden onset of severe headache, neck stiffness, and altered sensorium. CSF analysis shows lymphocytic pleocytosis (180 cells/μL, predominantly lymphocytes), elevated protein (120 mg/dL), and low glucose (28 mg/dL). What is the most appropriate immediate next step?

Explanation

## TB Meningitis: Recognition and Management ### Clinical Scenario Analysis This child has developed **tuberculous meningitis (TBM)** while on ATT — a serious complication that can occur early (paradoxical worsening) or late in treatment. **Key Point:** TB meningitis is the most severe form of extrapulmonary TB in children. It requires: 1. Continuation of ATT (do NOT stop) 2. Optimization with **high-dose, CNS-penetrating drugs** 3. **Adjunctive corticosteroids** to reduce inflammation and prevent complications ### CSF Findings Diagnostic of TBM | Parameter | Finding | Interpretation | |-----------|---------|----------------| | **Cell count** | 180/μL, lymphocytic | Lymphocytic pleocytosis (classic for TBM) | | **Protein** | 120 mg/dL | Elevated (TBM: 100–500 mg/dL) | | **Glucose** | 28 mg/dL | **Low** (CSF:plasma ratio <0.5; hallmark of TBM) | | **Gram stain** | Negative (usually) | AFB smear often negative; culture gold standard | **High-Yield:** The **low CSF glucose with elevated protein and lymphocytic pleocytosis** is pathognomonic for TBM. Do NOT wait for AFB culture confirmation (takes weeks); start treatment immediately. ### Management of TB Meningitis ```mermaid flowchart TD A[Suspected TB Meningitis]:::outcome --> B[Confirm with CSF analysis]:::action B --> C{CSF findings consistent?}:::decision C -->|Yes| D[Continue ATT - do NOT stop]:::action D --> E[Optimize drug regimen for CNS]:::action E --> F[High-dose INH + RIF + PZA + Fluoroquinolone]:::action F --> G[Add high-dose corticosteroids]:::action G --> H[Dexamethasone 0.3 mg/kg/day × 6-8 weeks]:::action H --> I[Repeat CSF at 2-4 weeks]:::action I --> J[Monitor for complications]:::action J --> K[Hydrocephalus, stroke, spinal TB]:::urgent ``` ### Optimal Drug Regimen for TB Meningitis **High-dose CNS-penetrating drugs:** | Drug | Standard Dose (mg/kg) | **TBM Dose (mg/kg)** | CNS Penetration | |------|----------------------|----------------------|------------------| | **INH** | 10 | **15–20** | Excellent | | **RIF** | 15 | **15–20** | Good | | **PZA** | 25 | **30–40** | Excellent | | **Fluoroquinolone** (Levofloxacin) | — | **15–20** | Moderate–Good | | **Streptomycin** | 15 | **15–20** | Poor (avoid if possible) | **Mnemonic:** **HIFQ** — High-dose INH, Fluoroquinolone, plus standard RIF and PZA for TB meningitis. ### Adjunctive Corticosteroids **Key Point:** Dexamethasone reduces inflammation, prevents hydrocephalus, and improves outcomes in TBM. - **Dose:** 0.3 mg/kg/day (max 4 mg/day) for 6–8 weeks, then taper - **Timing:** Start with or shortly after first dose of ATT - **Evidence:** Reduces mortality and disability in children with TBM **Clinical Pearl:** Corticosteroids should NOT delay ATT initiation. Both are started together. ### Why This Is Likely Paradoxical TB Meningitis The child developed meningitis **while already on ATT** (after 2 weeks). This is a recognized phenomenon called **paradoxical worsening** or **immune reconstitution inflammatory syndrome (IRIS)**, where: - Dying bacilli release antigens - Immune response intensifies, causing inflammation - CSF sterilization lags behind clinical improvement - **Management:** Continue ATT + optimize + add corticosteroids (do NOT stop ATT) ## Why Other Options Are Incorrect **Option 0 (Continue current ATT + high-dose INH + fluoroquinolone):** Incomplete. While high-dose INH and fluoroquinolone are correct, this option omits the critical adjunct of **corticosteroids**, which are essential to reduce inflammation and prevent complications (hydrocephalus, stroke). **Option 1 (Discontinue ATT, imaging, empiric meningitis cover):** Dangerous. Stopping ATT in TB meningitis is harmful and will lead to disease progression. The diagnosis is already supported by CSF findings; empiric bacterial meningitis cover is unnecessary. Imaging (CT/MRI) can be done but should NOT delay ATT + corticosteroid initiation. **Option 3 (Switch to second-line ATT immediately):** Incorrect. First-line drugs (INH, RIF, PZA) are highly effective for TB meningitis when given in high doses. Second-line drugs (bedaquiline, linezolid) are reserved for **drug-resistant TB**, which is not indicated here. The child is on standard ATT, and there is no evidence of resistance. ## Summary of Correct Management 1. **Continue ATT** (do not stop) 2. **Optimize dosing** — high-dose INH, RIF, PZA, + fluoroquinolone 3. **Add dexamethasone** — 0.3 mg/kg/day × 6–8 weeks 4. **Monitor CSF** — repeat at 2–4 weeks 5. **Watch for complications** — hydrocephalus, TB vasculitis, spinal TB